First Successful Implant of FDA-Approved Duo Venous Stent System Offers New Hope for Chronic Venous Insufficiency Patients

Philips announced the first U.S. patient was successfully treated at Sanger Heart & Vascular Clinic with the Duo Venus Stent System, an implantable medical device for chronic venous insufficiency (CVI).

Related Keywords

,Erin Murphy ,Atrium Health Sanger Heart Vascular Institute ,Should Know ,Philipsduo Venous Stent System ,Atrium Health ,Sanger Heart ,Vascular Institute ,Common Yet Complex Cardiovascular ,Duo Venous Stent System ,Philips Duo Venous Stent System ,Duo Hybrid ,Duo Extend ,Trial Success Paves ,Improved Quality ,